The groundbreaking treatment of the medication represents a significant advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide747460.izrablog.com/42371510/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment